Malika Hamdane

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's disease.

N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's disease.

Journal: Translational neurodegeneration

Published: October 21, 2025

Phospho-Tau Signature During Mitosis: AT8, p-T217 and p-S422 as Key Phospho-Epitopes.

Phospho-Tau Signature During Mitosis: AT8, p-T217 and p-S422 as Key Phospho-Epitopes.

Journal: Cells

Published: August 03, 2025

FTLD-MAPT mutations and short 5'UTR Tau mRNAs increase Tau translation.

FTLD-MAPT mutations and short 5'UTR Tau mRNAs increase Tau translation.

Journal: NAR molecular medicine

Published: October 04, 2024

Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.

Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.

Journal: Brain : a journal of neurology

Published: November 30, 2023

Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey.

Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey.

Journal: Biomedicines

Published: December 21, 2021

Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor.

Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor.

Journal: Brain : a journal of neurology

Published: March 19, 2019

Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.

Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.

Journal: Neurobiology of disease

Published: October 24, 2018

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease.

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease.

Journal: Neurobiology of disease

Published: July 24, 2018

Tau deletion promotes brain insulin resistance.

Tau deletion promotes brain insulin resistance.

Journal: The Journal of experimental medicine

Published: October 12, 2016

The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function.

The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function.

Journal: Scientific reports

Published: April 07, 2016

A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

Journal: Molecular psychiatry

Published: July 29, 2015

Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism.

Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism.

Journal: ACS chemical neuroscience

Published: January 23, 2015

Showing 1-12 of 23

Last Updated: 09/26/2026